About 2-[4-[5-[[(2S)-1-[6-oxo-5-(trifluoromethyl)diazinan-4-yl]pyrrolidin-2-yl]methoxy]pyridine-3-carbonyl]piperazin-1-yl]pyrimidine-5-carbonitrile
2-[4-[5-[[(2S)-1-[6-oxo-5-(trifluoromethyl)diazinan-4-yl]pyrrolidin-2-yl]methoxy]pyridine-3-carbonyl]piperazin-1-yl]pyrimidine-5-carbonitrile (PubChem CID 154825740) has the molecular formula C25H28F3N9O3
and a molecular weight of 559.55 g/mol. Its IUPAC name is 2-[4-[5-[[(2S)-1-[6-oxo-5-(trifluoromethyl)diazinan-4-yl]pyrrolidin-2-yl]methoxy]pyridine-3-carbonyl]piperazin-1-yl]pyrimidine-5-carbonitrile.
Molecular Properties
| Compound Name | 2-[4-[5-[[(2S)-1-[6-oxo-5-(trifluoromethyl)diazinan-4-yl]pyrrolidin-2-yl]methoxy]pyridine-3-carbonyl]piperazin-1-yl]pyrimidine-5-carbonitrile |
| PubChem CID | 154825740 |
| Molecular Formula | C25H28F3N9O3 |
| Molecular Weight | 559.55 g/mol |
| Exact Mass | 559.23 |
| IUPAC Name | 2-[4-[5-[[(2S)-1-[6-oxo-5-(trifluoromethyl)diazinan-4-yl]pyrrolidin-2-yl]methoxy]pyridine-3-carbonyl]piperazin-1-yl]pyrimidine-5-carbonitrile |
| SMILES | N#Cc1cnc(N2CCN(C(=O)c3cncc(OC[C@@H]4CCCN4C4CNNC(=O)C4C(F)(F)F)c3)CC2)nc1 |
| InChI | InChI=1S/C25H28F3N9O3/c26-25(27,28)21-20(14-33-34-22(21)38)37-3-1-2-18(37)15-40-19-8-17(12-30-13-19)23(39)35-4-6-36(7-5-35)24-31-10-16(9-29)11-32-24/h8,10-13,18,20-21,33H,1-7,14-15H2,(H,34,38)/t18-,20?,21?/m0/s1 |
| InChIKey | IQWSJXUVWMCCLX-PELRDEGISA-N |
| XLogP | 0.73 |
| TPSA | 139.61 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 40 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
| MW ≤ 500 | 559.55 |
| LogP ≤ 5 | 0.73 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 10 |
Analyze 2-[4-[5-[[(2S)-1-[6-oxo-5-(trifluoromethyl)diazinan-4-yl]pyrrolidin-2-yl]methoxy]pyridine-3-carbonyl]piperazin-1-yl]pyrimidine-5-carbonitrile with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 2-[4-[5-[[(2S)-1-[6-oxo-5-(trifluoromethyl)diazinan-4-yl]pyrrolidin-2-yl]methoxy]pyridine-3-carbonyl]piperazin-1-yl]pyrimidine-5-carbonitrile?
The IUPAC name of 2-[4-[5-[[(2S)-1-[6-oxo-5-(trifluoromethyl)diazinan-4-yl]pyrrolidin-2-yl]methoxy]pyridine-3-carbonyl]piperazin-1-yl]pyrimidine-5-carbonitrile (CID 154825740) is 2-[4-[5-[[(2S)-1-[6-oxo-5-(trifluoromethyl)diazinan-4-yl]pyrrolidin-2-yl]methoxy]pyridine-3-carbonyl]piperazin-1-yl]pyrimidine-5-carbonitrile.
What is the SMILES notation for 2-[4-[5-[[(2S)-1-[6-oxo-5-(trifluoromethyl)diazinan-4-yl]pyrrolidin-2-yl]methoxy]pyridine-3-carbonyl]piperazin-1-yl]pyrimidine-5-carbonitrile?
The canonical SMILES for 2-[4-[5-[[(2S)-1-[6-oxo-5-(trifluoromethyl)diazinan-4-yl]pyrrolidin-2-yl]methoxy]pyridine-3-carbonyl]piperazin-1-yl]pyrimidine-5-carbonitrile is N#Cc1cnc(N2CCN(C(=O)c3cncc(OC[C@@H]4CCCN4C4CNNC(=O)C4C(F)(F)F)c3)CC2)nc1.
What is the InChIKey of 2-[4-[5-[[(2S)-1-[6-oxo-5-(trifluoromethyl)diazinan-4-yl]pyrrolidin-2-yl]methoxy]pyridine-3-carbonyl]piperazin-1-yl]pyrimidine-5-carbonitrile?
The InChIKey is IQWSJXUVWMCCLX-PELRDEGISA-N. The full InChI is InChI=1S/C25H28F3N9O3/c26-25(27,28)21-20(14-33-34-22(21)38)37-3-1-2-18(37)15-40-19-8-17(12-30-13-19)23(39)35-4-6-36(7-5-35)24-31-10-16(9-29)11-32-24/h8,10-13,18,20-21,33H,1-7,14-15H2,(H,34,38)/t18-,20?,21?/m0/s1.
What are the key properties of 2-[4-[5-[[(2S)-1-[6-oxo-5-(trifluoromethyl)diazinan-4-yl]pyrrolidin-2-yl]methoxy]pyridine-3-carbonyl]piperazin-1-yl]pyrimidine-5-carbonitrile?
2-[4-[5-[[(2S)-1-[6-oxo-5-(trifluoromethyl)diazinan-4-yl]pyrrolidin-2-yl]methoxy]pyridine-3-carbonyl]piperazin-1-yl]pyrimidine-5-carbonitrile has a molecular weight of 559.55 g/mol, XLogP of 0.73, 6 rotatable bonds, 2 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-[5-[[(2S)-1-[6-oxo-5-(trifluoromethyl)diazinan-4-yl]pyrrolidin-2-yl]methoxy]pyridine-3-carbonyl]piperazin-1-yl]pyrimidine-5-carbonitrile is sourced from PubChem (CID 154825740), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).